Menu
  • Home
  • About
  • Distributors
  • Investors
Pressure BioSciences Inc
Menu
  • Technology
  • Products
  • Publications
  • Contract Services
  • Contact

Press Releases

Investors
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Audio and Video
    • Email Alerts
  • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All Filings
    • Annual Reports
    • Proxy Statements
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

News / Events

  • Press Releases
  • IR Calendar
  • Audio and Video
  • Email Alerts

Pressure BioSciences, Inc. to Discuss Third Quarter 2022 Financial Results and Provide Business Update

Nov 21, 2022

Pressure BioSciences and Leading Cosmeceuticals Innovator Dr. Denese SkinScience to Introduce Revolutionary UST Nanoemulsion Hair Regrowth Product in 2023

Oct 26, 2022

Pressure BioSciences and Leading Cosmeceuticals Company Dr. Denese SkinScience Present Their Partnership Progress in FORCE Family Office October 13th Webinar

Oct 11, 2022

Imminent Commercial Launch of Revolutionary UST Processing Method to be Focus of Pressure BioSciences Presentation at Emerging Growth Conference 40 on September 28, 2022

Sep 28, 2022

Unique Advantages and Commercial Process Scalability of Pressure BioSciences Revolutionary UST Platform Illuminated at the Conference of Food Engineering 2022

Sep 27, 2022

Pressure BioSciences to Expand on Pivotal Change in Business Strategy with Presentation at H. C. Wainwright Annual Global Investment Conference on September 13th

Sep 13, 2022

Pressure BioSciences Secures Pivotal Cosmeceuticals Partnership for UST Platform With Dr. Denese SkinScience, 20-Year Leader With Over $0.5 Billion in QVC Sales

Aug 24, 2022

Pressure BioSciences Announces Contract for October 2022 Launch of Breakthrough Hemp-Derived CBD Product, Estimating $2 Million Incremental 2023 Revenue

Aug 18, 2022

Pressure BioSciences, Inc. to Discuss Second Quarter 2022 Financial Results and Provide Business Update

Aug 16, 2022

Pressure BioSciences Announces Approval to Manufacture Hemp-Derived CBD Products in Massachusetts, Including Their Revolutionary CBD Nanoemulsions

Aug 11, 2022
RSS
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • ...47

    Browse Our Site

    • Home
    • About
    • Distributors
    • Investors
    • Technology
    • Products
    • Publications
    • Contract Services
    • Contact

    Visit Us

    • Headquarters
    • 480 Neponset Street, Unit 10B
    • Canton, MA 02021

    Connect With Us

    Talk To Us

    • P (508) 230.1828
    • F (508) 230.1829
    • E info@pressurebiosciences.com
    • SEND US A MESSAGE
    • Privacy Policy
    • Returns & Refunds
    • Terms & Conditions/Delivery & Shipment
    • Disclaimer

    © 2025 Pressure BioSciences, Inc. All Rights Reserved. Website by Interactive Palette